LogoLogoMSF Science Portal
  • My saved items
logo

© Médecins Sans Frontières

MSF Science Portal
About MSF Science Portal
About MSF
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use

v2.1.4829.produseast1

Journal Article > Case Report/Series

Seizure activity and anion gap metabolic acidosis secondary to adverse effect of nalidixic acid—a case report

Galvin M, Al Qaisy MS, Cajazeiro J
Download
Download
Abstract
Nalidixic acid is a commonly prescribed treatment for suspected dysentery in Middle Eastern populations. We describe a case of convulsions resulting from a single dose of nalidixic acid in a previously healthy two-month-old child in Northern Iraq who was being treated for a diarrhoeal illness. The child presented to us with new onset seizures, irritability, and acidaemia. Nalidixic acid was thought to be responsible after the exclusion of other potential causes of seizures. Symptoms resolved by treatment with intravenous (IV) diazepam, and cessation of nalidixic acid, and the child recovered fully and was discharged home neurologically intact after two days of observation. In regions where it is commonly prescribed, such as Northern Iraq, nalidixic acid should be considered as a cause of convulsions in any seizing child who has been exposed to the drug. Furthermore, quinolones such as nalidixic acid are contraindicated in children < 3 months of age.
Countries
Iraq
DOI
10.1093/omcr/omaa120
Published Date
01-Jan-2021
PubMed ID
33469471
Languages
English
Journal
Oxford Medical Case Reports
Volume / Issue / Pages
Volume 2021, Issue 1, Pages omaa120
Dimensions Badge